Skip to main content
Premium Trial:

Request an Annual Quote

UK Government Investigating Illumina's Proposed Acquisition of Pacific Biosciences

NEW YORK (GenomeWeb) – The UK government's Competition and Markets Authority (CMA) said today that it has launched an investigation into Illumina's planned acquisition of Pacific Biosciences.

Illumina announced last November that it plans to acquire PacBio for approximately $1.2 billion in cash. In January, the company reiterated that it expects the acquisition to close mid-year.

CMA is currently considering whether the acquisition "will result in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002" and whether it will likely result "in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services." Until May 3, stakeholders are invited to send the agency comments on competition issues.

CMA, a non-ministerial department of the UK government, is in charge of promoting competition and reducing anti-competitive activities in the UK. Among other actions, it investigates mergers that could restrict competition.

Illumina and PacBio both declined to comment on the CMA investigation.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.